Tumor immunotherapy, especially PD-1/PD-L1 ICIs, has shown rapid progress in the field of tumor treatment in recent years, and it has become another important tumor treatment method after surgery, radiotherapy, and chemotherapy. The gene discussed is CD274; the disease is neoplasm.